Ghrelin alleles and use of the same for genetically typing animals by Rothschild, Max F. et al.
Iowa State University Patents Iowa State University Research Foundation, Inc.
7-11-2006
Ghrelin alleles and use of the same for genetically
typing animals
Max F. Rothschild
Iowa State University, mfrothsc@iastate.edu
Kwan-Suk Kim
Iowa State University
Lloyd L. Anderson
Iowa State University, llanders@iastate.edu
Follow this and additional works at: http://lib.dr.iastate.edu/patents
Part of the Animal Sciences Commons
This Patent is brought to you for free and open access by the Iowa State University Research Foundation, Inc. at Iowa State University Digital
Repository. It has been accepted for inclusion in Iowa State University Patents by an authorized administrator of Iowa State University Digital
Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Rothschild, Max F.; Kim, Kwan-Suk; and Anderson, Lloyd L., "Ghrelin alleles and use of the same for genetically typing animals"
(2006). Iowa State University Patents. 241.
http://lib.dr.iastate.edu/patents/241
Ghrelin alleles and use of the same for genetically typing animals
Abstract
Disclosed herein are genetic markers for animal growth, appetite and fatness, methods for identifying such
markers, and methods of screening animals to determine those more likely to produce desired growth,
appetite and fatness and preferably selecting those animals for future breeding purposes. The markers are
based upon the presence or absence of certain polymorphisms in the Ghrelin gene.
Keywords
Animal Science
Disciplines
Animal Sciences
This patent is available at Iowa State University Digital Repository: http://lib.dr.iastate.edu/patents/241
(12) United States Patent 
Rothschild et al. 
US007074562B2 
US 7,074,562 B2 
Jul. 11, 2006 
(10) Patent N0.: 
(45) Date of Patent: 
(54) 
(75) 
(73) 
(21) 
(22) 
(65) 
(60) 
(51) 
(52) 
(58) 
GHRELIN ALLELES AND USE OF THE 
SAME FOR GENETICALLY TYPING 
ANIMALS 
Inventors: Max F. Rothschild, Ames, IA (US); 
KWan-Suk Kim, Ames, IA (US); Lloyd 
L. Anderson, Ames, IA (US) 
Assignee: Iowa State University Research 
Foundation, Inc., Ames, IA (US) 
Notice: Subject to any disclaimer, the term of this 
patent is extended or adjusted under 35 
U.S.C. 154(b) by 375 days. 
Appl. No.: 10/294,191 
Filed: Nov. 14, 2002 
Prior Publication Data 
US 2003/0211512 A1 Nov. 13, 2003 
Related US. Application Data 
Provisional application No. 60/333,222, ?led on Nov. 
14, 2001. 
Int. Cl. 
C12Q 1/68 (2006.01) 
C12P 19/34 (2006.01) 
US. Cl. ........................................ .. 435/6; 435/91.2 
Field of Classi?cation Search .................. .. 435/6; 
536/231 
See application ?le for complete search history. 
(56) References Cited 
OTHER PUBLICATIONS 
Skibola et al. “Polymorphisms in Ghrelin and Neuropeptide 
Y Genes are Associated With Non-Hodgkin Lymphoma.” 
Cancer Epidemiology Biomarkers Prevention. May 2005, 
14(5). pp. 1251-1256.* 
Thisted, R. “What is a P-value” (1998) Http://WWW.stat. 
uchicago.edu/ Thisted.* 
* cited by examiner 
Primary Examiner4Gary BenZion 
Assistant Examiner4Christopher M. Babic 
(74) Attorney, Agent, or F irmiMcKee, Voorhees & Sease, 
P.L.C. 
(57) ABSTRACT 
Disclosed herein are genetic markers for animal growth, 
appetite and fatness, methods for identifying such markers, 
and methods of screening animals to determine those more 
likely to produce desired groWth, appetite and fatness and 
preferably selecting those animals for future breeding pur 
poses. The markers are based upon the presence or absence 
of certain polymorphisms in the Ghrelin gene. 
6 Claims, 9 Drawing Sheets 

U.S. Patent Jul. 11,2006 Sheet 2 0f 9 US 7,074,562 B2 
11 
MONOMORPHIC J 
FRAGMENT 
Fig. 2A 
11 
360 
350 
ALLELE1—> - _ 
ALLELEZ» - 
MONOMORPHIC 
FRAGMENT —* - - 
Fig.2B 
11 
1 100 
800 
300 
AU.ELEI—> — - 
ALLELE2—> 
Fig.2C 
U.S. Patent Jul. 11,2006 Sheet 3 0f 9 US 7,074,562 B2 
11 
580 
500 
380 
140 
MONOMORPHIC ‘*7 
FRAGMENT ‘ 
Fig. 2D 
11 
510 
500 
380 
140 
Al.LELE1-—> - 
AliELEZ 
MONOMORPHIC 
FRAGMENT -—> - - 
Fig. 2E 
11 
1100 
650 
450 
ALLELE1—-> - - 
ALLELE2—> - 
Fig. 2F 
U.S. Patent Jul. 11,2006 Sheet 4 0f 9 US 7,074,562 B2 
11 
00 o80 2Al 55 32
0 0W6 
: 4'2 mm 
MONOMORPHIC / 
FRAGMENT 
H 
370 
250 
1 20 
80 
ALLELII1—> - - 
ALLELE2—>- - 
MONOMORPHIC 
Fig. 2H 
U.S. Patent Jul. 11,2006 Sheet 5 0f 9 US 7,074,562 B2 
Start codon 
EKGCTGAGGCCATGCCCTCCACGGGGACCATTTGCAGCCTGCTGCTCCTCAGCGTGCTCCTCATI 
[GGCAGACTTGGCCATGGCGGGCTCCAGCTTCTTGAGCCCCGAACACCAGAAAGTGCAGIGTAA 
GACGTCTCCCCAGAGCCCCQGCTTCTGGCGGGTACCTCATCCCAGCCCTTCCATGAGTTGGGA 
A 
CCTGGGCTCACCTGCTCTGGGCTTCAGGCCTCTCCCAAGGAGGACTCTGGATCTGCAAGGGAG 
G 
CCCATACCTTGCTCTGCTTCTGGAAGGAAGTAGTGGGGGTGGGTGGGCATCTTAGGGCCTC 
AAGAGAGCAGTTCCTCTTTCCAGCAGAG AAAGGAGTCCAAGAAGCCAGCAGCCAAACTGAA| 
IGCCCCGGGCCCTGGAAGGCTGGCTCGGCCCAGAAGACAGTGGTGAG GTGGAAGGCACGGI 
AGGACAAQCTGGAAA SEQ ID NO: 11 
Fig 3 
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ITCAGTCCGACCAGCACGGCCAGCCCCTGGGGAAATTTCTCCAGGACATCCTCTGGGAA j 
TAAGTCCCCGTCCCGGCTAAGGTCAATTCCAAGTTCCTGGGAGTCCCA 
GTGTGAGCCCATCTATGGGTAACAAAACAGAAATI'TCCTI'CCCCATCCCTGCCTCTCTAA 
AGAGCTTCTGTGGCCTTCTGTGGCACAGGATCCAATGTI'GTTACTATAGAQ‘ITITGGGTC 
G A 
ACTGCAGTGGTGTGGGCCTGGGAAGTI'CCACATGCTG CAAGT_A_CAG CCAAAAAATAAAA 
G 
AAGGGCCTTTAATTGCTCTITCCCGGGAGTTCCCGTTGTGGCTCAGCAGTTAGCGAATCT 
C 
GACTAGCATCCATGAGGATGCAGGTTCGATCCCTGGCCTFACTCAGTG GGTFAAAGATC 
G 
TG GCATFGCCGTGAACTGTGGTGTAGTI'G CAGACACGGCTCAQATCCTG CATTGCTGTG 
G A 
TCTGTGGTGTAGGCCGGTAGCTACAGCTCCGATITGACCCCTAAC CTGGGAACCTNC'IT 
ATGCTGCAAGTGCTGCCCTGAAAAAGCTGNNNNNNNNNNNNNNNNNNN 
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNl l I I l I l l I l I I l ICCCCI I l l l I I l I 
TTTTI'T'ITTGGCCATGCGTGCAGCATGCCAATGTTCCTAGGCCAGGGAACCCAAGCCAC 
AGCAGTGACAACCCTGGATCCTI'AAGGAACTAGGCCACCAGGGAACTCCAGAAAAGCCA 
TCTCTGATGGCAAIGGCAGAACAGCACAGAATTTTGACTTGATCTCTTGCTTTTCAGAIEI 
C 
CCCCGGCCGACAAGTG GTCCCTGAGACCAGCCACCTCTGTTCTCCCAGCQTCCTAA 
Stop codon T 
GGGCTCACNTGGCTTACAGTACGCTI'CC SEQ ID NO: 12 
Fig. 4 
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GHRELIN ALLELES AND USE OF THE 
SAME FOR GENETICALLY TYPING 
ANIMALS 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
This application claims bene?t under 35 USC § ll9(e) 
of provisional application No. 60/333,222, ?led Nov. 14, 
2001, the disclosure of Which is hereby incorporated by 
reference in its entirety. 
GRANT REFERENCE 
This invention Was supported at least in part by USDA/ 
CREES contract number 2001-31200-06019 (IHAEES 
project number IOWO3600). The United States government 
may have certain rights in this invention. 
BACKGROUND OF THE INVENTION 
Genetic differences exist among individual animals as 
Well as among breeds Which can be exploited by breeding 
techniques to achieve animals With desirable characteristics. 
For example, Chinese breeds are knoWn for reaching 
puberty at an early age and for their large litter siZe, While 
American breeds are knoWn for their greater groWth rates 
and leanness. HoWever, heritability for desired traits is often 
loW, and standard breeding methods Which select individuals 
based upon phenotypic variations do not take fully into 
account genetic variability or complex gene interactions 
Which exist. 
Restriction fragment length polymorphism (RFLP) analy 
sis has been used by several groups to study pig DNA. Jung 
et al., Theo}: Appl. Genet, 77:27l4274 (1989), incorporated 
herein by reference, discloses the use of RFLP techniques to 
shoW genetic variability betWeen tWo pig breeds. Polymor 
phism Was demonstrated for sWine leukocyte antigen (SLA) 
Class I genes in these breeds. Hoganson et al., Abstract for 
Annual Meeting of Midwestern Section of the American 
Society ofAnimal Science, Mar. 26428, 1990, incorporated 
herein by reference, reports on the polymorphism of sWine 
major histocompatibility complex (MHC) genes for Chinese 
pigs, also demonstrated by RFLP analysis. Jung et al., Theor. 
Appl. Genet, 77:27l4274 (1989), incorporated herein by 
reference, reports on RFLP analysis of SLA Class I genes in 
certain boars. The authors state that the results suggest that 
there may be an association betWeen sWine SLA/MHC Class 
I genes and production and performance traits. They further 
state that the use of SLA Class I restriction fragments, as 
genetic markers, may have potential in the future for 
improving pig groWth performance. 
The ability to folloW a speci?c favorable genetic allele 
involves a novel and lengthy process of the identi?cation of 
a DNA molecular marker for a major effect gene. The 
marker may be linked to a single gene With a major effect or 
linked to a number of genes With additive effects. DNA 
markers have several advantages; segregation is easy to 
measure and is unambiguous, and DNA markers are co 
dominant, i.e., heterozygous and homozygous animals can 
be distinctively identi?ed. Once a marker system is estab 
lished selection decisions could be made very easily, since 
DNA markers can be assayed any time after a tissue or blood 
sample can be collected from the individual infant animal, or 
even an embryo. 
The use of genetic differences in receptor genes has 
become a valuable marker system for selection. For 
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example, US. Pat. Nos. 5,550,024 and 5,374,526 issued to 
Rothschild et al. disclose a polymorphism in the pig estrogen 
receptor gene Which is associated With larger litter siZe, the 
disclosure of Which is incorporated herein by reference. US. 
Pat. No. 5,935,784 discloses polymorphic markers in the pig 
prolactin receptor gene Which are associated With larger 
litter siZe and overall reproductive ef?ciency. 
Litter siZe, of course has a direct economic impact for a 
breeder. Also important for meat producing animals is 
groWth, appetite and fatness. 
The quality of raW pig meat is in?uenced by a large 
number of genetic and non-genetic factors. The latter 
include farm, transport, slaughter and processing conditions. 
Meat scientists have performed a substantial amount of 
research on these factors, Which has led to considerable 
quality improvement. Part of the research has also been 
dedicated to the genetic background of the animals, and 
several studies have revealed the importance of genetic 
factors. This has made the industry aWare that selective 
breeding of animals and the use of gene technology can play 
an important role in enhancing pork quality. 
Information at the DNA level can not only help to ?x a 
speci?c major gene, but it can also assist the selection of 
quantitative traits for Which We already select. Molecular 
information in addition to phenotypic data can increase the 
accuracy of selection and therefore the selection response. 
The siZe of the extra response in such a Marker Assisted 
Selection (MAS) program has been considered by many 
Workers from a theoretical point of vieW. In general terms, 
MAS is more bene?cial for traits With a loW heritability and 
Which are expensive to measure phenotypically. Although 
traits such as groWth, appetite and fatness are not typically 
considered in this Way, there are still signi?cant advantages 
for the use of markers for these traits. For example, Meu 
Wissen and Goddard considered the impact of MAS for 
different types of traits. The biggest impacts Were for traits 
such as meat quality, Where the trait is measured after 
slaughter and an additional response of up to 64% could be 
achieved With the incorporation of marker information. This 
?gure Was relatively small, 8%, for groWth traits that can be 
measured on the live animal. HoWever, once the association 
has been demonstrated this marker information can be used 
before the animals are tested or selected phenotypically (see 
beloW) and in this situation a response of up to 38% Was 
predicted. 
Indeed, the best approach to genetically improve eco 
nomic traits is to ?nd relevant DNA-markers directly in the 
population under selection. Phenotypic measurements can 
be performed continuously on some animals from the 
nucleus populations of breeding organiZations. Since a full 
assessment of most of these traits can only be done after 
slaughter, the data must be collected on culled animals and 
cannot be obtained on potential breeding animals. 
This phenotypic data is collected in order to enable the 
detection of relevant DNA markers, and to validate markers 
identi?ed using experimental populations or to test candi 
date genes. Signi?cant markers or genes can then be 
included directly in the selection process. An advantage of 
the molecular information is that We can obtain it at a very 
young age in the breeding animal, Which means that animals 
can be preselected based on DNA markers before the groW 
ing performance test is completed. This is a great advantage 
for the overall testing and selection system. 
It can be seen from the foregoing that a need exists for 
identi?cation of markers Which may be used to improve 
US 7,074,562 B2 
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economically bene?cial characteristics in animals by iden 
tifying and selecting animals With the improved character 
istics at the genetic level. 
An object of the present invention is to provide a genetic 
marker based on or Within the Ghrelin gene Which is 
indicative of favorable economic characteristics such as 
groWth, appetite and fatness. 
Another object of the invention is to provide an assay for 
determining the presence of this genetic marker. 
A further object of the invention is to provide a method of 
evaluating animals that increases accuracy of selection and 
breeding methods for the desired traits. 
Yet another object of the invention is to provide a PCR 
ampli?cation test Which Will greatly expedite the determi 
nation of presence of the marker. 
Additional objects and advantages of the invention Will be 
set forth in part in the description that folloWs, and in part 
Will be obvious from the description, or may be learned by 
the practice of the invention. The objects and advantages of 
the invention Will be attained by means of the instrumen 
talities and combinations particularly pointed out in the 
appended claims. 
BRIEF SUMMARY OF THE INVENTION 
This invention relates to the discovery of alternate gene 
forms of the Ghrelin gene Which are useful as genetic 
markers associated With groWth, appetite and fatness traits in 
animals. To the extent that these genes are conserved among 
species and animals, it is expected that the different alleles 
disclosed herein Will also correlate With variability in this 
gene in other economic or meat-producing animals such as 
bovine, sheep, chicken, etc. 
To achieve the objects and in accordance With the purpose 
of the invention, as embodied and broadly described herein, 
the present invention provides the discovery of alternate 
genotypes Which provide a method for screening animals to 
determine those more likely to possess favorable groWth, 
appetite and fatness traits or to select against pigs Which 
have alleles indicating less favorable groWth, appetite and 
fatness traits. As used herein “favorable groWth, appetite and 
fatness trait” means a signi?cant improvement (increase or 
decrease) in one of many measurable groWth, appetite and 
fatness traits above the mean of a given population, so that 
this information can be used in breeding to achieve a 
uniform population Which is optimiZed for groWth, appetite 
and fatness, this may include an increase in some traits or a 
decrease in others depending on the desired characteristics. 
For a revieW of economic traits the folloWing may be 
consulted: Sosnicki, A. A., E. R. Wilson, E. B. Sheiss, A. 
deVries, 1998, “Is there a cost effective Way to produce high 
quality pork?”, Reciprocal Meal Conference Proceedings, 
Vol. 51. 
Thus, the present invention provides a method for screen 
ing pigs to identify those more likely to produce favorable 
groWth, appetite and fatness, and/or those less likely to 
produce favorable groWth, appetite and fatness to optimiZe 
breeding and selection techniques for the best groWth, 
appetite and fatness. 
Methods for assaying for these traits generally comprises 
the steps 1) obtaining a biological sample from a pig; and 2) 
analyZing the genomic DNA or protein obtained in l) to 
determine Which Ghrelin allele(s) is/are present. Also 
included herein are haplotype data Which alloWs for a series 
of polymorphisms in the Ghrelin gene to be combined in a 
selection or identi?cation protocol to maximiZe the bene?ts 
of each of these markers. 
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Since several of the polymorphisms involve changes in 
amino acid composition of the Ghrelin protein, assay meth 
ods may even involve ascertaining the amino acid compo 
sition of the Ghrelin protein. Methods for this type or 
puri?cation and analysis typically involve isolation of the 
protein through means including ?uorescence tagging With 
antibodies, separation and puri?cation of the protein (i.e., 
through reverse phase HPLC system), and use of an auto 
mated protein sequencer to identify the amino acid sequence 
present. Protocols for this assay are standard and knoWn in 
the art and are disclosed in Ausubel et. al.(eds.), Short 
Protocols in Molecular Biology (4th ed. John Wiley and 
Sons 1999). 
In a preferred embodiment, a genetic sample is analyZed. 
Brie?y, a sample of genetic material is obtained from an 
animal, and the sample is analyZed to determine the presence 
or absence of a polymorphism in the Ghrelin gene that is 
correlated With improved groWth, appetite and fatness or 
both traits depending on the gene form. 
As is Well knoWn to those of skill in the art, a variety of 
techniques may be utiliZed When comparing nucleic acid 
molecules for sequence differences. These include by Way of 
example, restriction fragment length polymorphism analy 
sis, heteroduplex analysis, single strand conformation poly 
morphism analysis, denaturing gradient electrophoresis and 
temperature gradient electrophoresis. 
In a preferred embodiment, the polymorphism is a restric 
tion fragment length polymorphism and the assay comprises 
identifying the pig Ghrelin gene from isolated genetic mate 
rial; exposing the gene to a restriction enZyme that yields 
restriction fragments of the gene of varying length; separat 
ing the restriction fragments to form a restriction pattern, 
such as by electrophoresis or HPLC separation; and com 
paring the resulting restriction fragment pattern from a 
Ghrelin gene that is either knoWn to have or not to have the 
desired marker. If an animal tests positive for the markers, 
such animal can be considered for inclusion in the breeding 
program. If the animal does not test positive for the marker 
genotype the animal can be culled from the group and 
otherWise used. Use of haplotype data can also be incorpo 
rated With the screening for multiple alleles for different 
aspects of groWth, appetite and fatness. 
In a most preferred embodiment, the gene is isolated by 
the use of primers and DNApolymerase to amplify a speci?c 
region of the gene Which contains the polymorphism. Next 
the ampli?ed region is digested With a restriction enZyme 
and fragments are again separated. Visualization of the 
RFLP pattern is by simple staining of the fragments, or by 
labeling the primers or the nucleoside triphosphates used in 
ampli?cation. 
In another embodiment, the invention comprises a method 
for identifying a genetic marker for groWth, appetite and 
fatness in a particular population. Male and female pigs of 
the same breed or breed cross or similar genetic lineage are 
bred, and groWth, appetite and fatness produced by each pig 
is determined. A polymorphism in the Ghrelin gene of each 
pig is identi?ed and associated With the groWth, appetite and 
fatness. Preferably, RFLP analysis is used to determine the 
polymorphism (FIGS. 2AiH). 
In another embodiment, the invention comprises a method 
for identifying a genetic marker for groWth, appetite and 
fatness in any particular economic animal other than a pig. 
Based upon the highly conserved nature of this gene among 
different animals, it is expected that With no more than 
routine testing as described herein, this marker can be 
applied to different animal species to select for groWth, 
appetite and fatness based on the teachings herein. Male and 
US 7,074,562 B2 
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female animals of the same breed or breed cross or similar 
genetic lineage are bred, and the growth, appetite and fatness 
produced by each animal is determined and correlated. For 
other animals in Which sequences are available a BLAST 
comparison of sequences may be used to ascertain Whether 
the particular allele is analogous to the one disclosed herein. 
The analogous polymorphism Will be present in other ani 
mals and in other closely related genes. The term “analogous 
polymorphism” shall be a polymorphism Which is the same 
as any of those disclosed herein as determined by BLAST 
comparisons. 
The folloWing terms are used to describe the sequence 
relationships betWeen tWo or more nucleic acids or poly 
nucleotides: (a) “reference sequence”, (b) “comparison Win 
doW”, (c) “sequence identity”, (d) “percentage of sequence 
identity”, and (e) “substantial identity”. 
(a) As used herein, “reference sequence” is a de?ned 
sequence used as a basis for sequence comparison. In this 
case the reference is the Ghrelin sequence. A reference 
sequence may be a subset or the entirety of a speci?ed 
sequence; for example, as a segment of a full-length cDNA 
or gene sequence, or the complete cDNA or gene sequence. 
(b) As used herein, “comparison WindoW” includes ref 
erence to a contiguous and speci?ed segment of a poly 
nucleotide sequence, Wherein the polynucleotide sequence 
may be compared to a reference sequence and Wherein the 
portion of the polynucleotide sequence in the comparison 
WindoW may comprise additions or deletions (i.e., gaps) 
compared to the reference sequence (Which does not com 
prise additions or deletions) for optimal alignment of the tWo 
sequences. Generally, the comparison WindoW is at least 20 
contiguous nucleotides in length, and optionally can be 30, 
40, 50, 100, or longer. Those of skill in the art understand 
that to avoid a high similarity to a reference sequence due to 
inclusion of gaps in the polynucleotide sequence, a gap 
penalty is typically introduced and is subtracted from the 
number of matches. 
Methods of alignment of sequences for comparison are 
Well-knoWn in the art. Optimal alignment of sequences for 
comparison may be conducted by the local homology algo 
rithm of Smith and Waterman, Adv. Appl. Math. 2:482 
(1981); by the homology alignment algorithm of Needleman 
and Wunsch, J. Mol. Biol. 48:443 (1970); by the search for 
similarity method of Pearson and Lipman, Proc. Natl. Acad. 
Sci. 85:2444 (1988); by computeriZed implementations of 
these algorithms, including, but not limited to: CLUSTAL in 
the PC/Gene program by lntelligenetics, Mountain View, 
Calif.; GAP, BESTFIT, BLAST, FASTA, and TFASTA in the 
Wisconsin Genetics SoftWare Package, Genetics Computer 
Group (GCG), 575 Science Dr., Madison, Wis., USA; the 
CLUSTAL program is Well described by Higgins and Sharp, 
Gene 73:2374244 (1988); Higgins and Sharp, CABIOS 
5:1514153 (1989); Corpet, et al., Nucleic Acids Research 
16:10881490 (1988); Huang, et al., Computer Applications 
in the Biosciences 8:155465 (1992), and Pearson, et al., 
Methods in Molecular Biology 24:3074331 (1994). The 
BLAST family of programs Which can be used for database 
similarity searches includes: BLASTN for nucleotide query 
sequences against nucleotide database sequences; BLASTX 
for nucleotide query sequences against protein database 
sequences; BLASTP for protein query sequences against 
protein database sequences; TBLASTN for protein query 
sequences against nucleotide database sequences; and 
TBLASTX for nucleotide query sequences against nucle 
otide database sequences. See, Current Protocols in Molecu 
lar Biology, Chapter 19, Ausubel, et al., Eds., Greene 
Publishing and Wiley-lnterscience, NeW York (1995). 
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Unless otherWise stated, sequence identity/similarity val 
ues provided herein refer to the value obtained using the 
BLAST 2.0 suite of programs using default parameters. 
Altschul et a., Nucleic Acids Res. 25:338943402 (1997). 
SoftWare for performing BLAST analyses is publicly avail 
able, e.g., through the National Center for Biotechnology 
lnformation http:// WorldWide Web at hcbi.nlm.nih. gov. 
This algorithm involves ?rst identifying high scoring 
sequence pairs (HSPs) by identifying short Words of length 
W in the query sequence, Which either match or satisfy some 
positive-valued threshold score T When aligned With a Word 
of the same length in a database sequence. T is referred to 
as the neighborhood Word score threshold (Altschul et al., 
supra). These initial neighborhood Word hits act as seeds for 
initiating searches to ?nd longer HSPs containing them. The 
Word hits are then extended in both directions along each 
sequence for as far as the cumulative alignment score can be 
increased. Cumulative scores are calculated using, for nucle 
otide sequences, the parameters M (reWard score for a pair 
of matching residues; alWays >0) and N (penalty score for 
mismatching residues; alWays <0). For amino acid 
sequences, a scoring matrix is used to calculate the cumu 
lative score. Extension of the Word hits in each direction are 
halted When: the cumulative alignment score falls off by the 
quantity X from its maximum achieved value; the cumula 
tive score goes to Zero or beloW, due to the accumulation of 
one or more negative-scoring residue alignments; or the end 
of either sequence is reached. The BLAST algorithm param 
eters W, T, and X determine the sensitivity and speed of the 
alignment. The BLASTN program (for nucleotide 
sequences) uses as defaults a Wordlength (W) of 11, an 
expectation (E) of 10, a cutoff of 100, M:5, N:—4, and a 
comparison of both strands. For amino acid sequences, the 
BLASTP program uses as defaults a Wordlength (W) of 3, an 
expectation (E) of 10, and the BLOSUM62 scoring matrix 
(see Henikolf & Henikolf (1989) Proc. Natl. Acad. Sci. USA 
89: 1091 5). 
In addition to calculating percent sequence identity, the 
BLAST algorithm also performs a statistical analysis of the 
similarity betWeen tWo sequences (see, e.g., Karlin & Alts 
chul, Proc. Natl. Acad. Sci. USA 90:587345787 (1993)). One 
measure of similarity provided by the BLAST algorithm is 
the smallest sum probability (P(N)), Which provides an 
indication of the probability by Which a match betWeen tWo 
nucleotide or amino acid sequences Would occur by chance. 
BLAST searches assume that proteins can be modeled as 
random sequences. HoWever, many real proteins comprise 
regions of nonrandom sequences Which may be homopoly 
meric tracts, short-period repeats, or regions enriched in one 
or more amino acids. Such loW-complexity regions may be 
aligned betWeen unrelated proteins even though other 
regions of the protein are entirely dissimilar. A number of 
loW-complexity ?lter programs can be employed to reduce 
such loW-complexity alignments. For example, the SEG 
(Wooten and Federhen, Comput. Chem., 17:1494163 
(1993)) and XNU (Claverie and States, Comput. Chem., 
17: 1914201 (1993)) loW-complexity ?lters can be employed 
alone or in combination. 
(c) As used herein, “sequence identity” or “identity” in the 
context of tWo nucleic acid or polypeptide sequences 
includes reference to the residues in the tWo sequences 
Which are the same When aligned for maximum correspon 
dence over a speci?ed comparison WindoW. When percent 
age of sequence identity is used in reference to proteins it is 
recogniZed that residue positions Which are not identical 
often differ by conservative amino acid substitutions, Where 
amino acid residues are substituted for other amino acid 
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residues With similar chemical properties (eg charge or 
hydrophobicity) and therefore do not change the functional 
properties of the molecule. Where sequences differ in con 
servative substitutions, the percent sequence identity may be 
adjusted upWards to correct for the conservative nature of 
the substitution. Sequences which differ by such conserva 
tive substitutions are said to have “sequence similarity” or 
“similarity”. Means for making this adjustment are Well 
knoWn to those of skill in the art. Typically this involves 
scoring a conservative substitution as a partial rather than a 
full mismatch, thereby increasing the percentage sequence 
identity. Thus, for example, Where an identical amino acid is 
given a score of l and a non-conservative substitution is 
given a score of Zero, a conservative substitution is given a 
score betWeen Zero and l. The scoring of conservative 
substitutions is calculated, e.g., according to the algorithm of 
Meyers and Miller, Computer Applic. Biol. Sci., 4zllil7 
(1988) e.g., as implemented in the program PC/GENE 
(lntelligenetics, Mountain View, Calif., USA). 
(d) As used herein, “percentage of sequence identity” 
means the value determined by comparing tWo optimally 
aligned sequences over a comparison WindoW, Wherein the 
portion of the polynucleotide sequence in the comparison 
WindoW may comprise additions or deletions (i.e., gaps) as 
compared to the reference sequence (Which does not com 
prise additions or deletions) for optimal alignment of the tWo 
sequences. The percentage is calculated by determining the 
number of positions at Which the identical nucleic acid base 
or amino acid residue occurs in both sequences to yield the 
number of matched positions, dividing the number of 
matched positions by the total number of positions in the 
Window of comparison and multiplying the result by 100 to 
yield the percentage of sequence identity. 
(e) The term “substantial identity” of polynucleotide 
sequences means that a polynucleotide comprises a 
sequence that has at least 70% sequence identity, preferably 
at least 80%, more preferably at least 90% and most pref 
erably at least 95%, compared to a reference sequence using 
one of the alignment programs described using standard 
parameters. One of skill Will recogniZe that these values can 
be appropriately adjusted to determine corresponding iden 
tity of proteins encoded by tWo nucleotide sequences by 
taking into account codon degeneracy, amino acid similarity, 
reading frame positioning and the like. Substantial identity 
of amino acid sequences for these purposes normally means 
sequence identity of at least 60%, or preferably at least 70%, 
80%, 90%, and most preferably at least 95%. 
These programs and algorithms can ascertain the analogy 
of a particular polymorphism in a target gene to those 
disclosed herein. It is expected that this polymorphism Will 
exist in other animals and be of use in other animals than 
disclosed herein involved no more than routine optimiZation 
of parameters using the teachings herein. 
It is also possible to establish linkage betWeen speci?c 
alleles of alternative DNA markers and alleles of DNA 
markers knoWn to be associated With a particular gene (e.g., 
the Ghrelin gene discussed herein), Which have previously 
been shoWn to be associated With a particular trait. Thus, in 
the present situation, taking the Ghrelin gene, it Would be 
possible, at least in the short term, to select for pigs likely to 
produce desired groWth, appetite and fatness, or alterna 
tively against pigs likely to produce less desirable groWth, 
appetite and fatness, indirectly, by selecting for certain 
alleles of a Ghrelin associated marker through the selection 
of speci?c alleles of alternative chromosome markers. As 
used herein, the term “genetic marker” shall include not only 
the polymorphism disclosed by any means of assaying for 
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the protein changes associated With the polymorphism, be 
they linked markers, use of microsatellites, or even other 
means of assaying for the causative protein changes indi 
cated by the marker, and the use of the marker to in?uence 
the groWth, appetite and fatness of an animal. 
As used herein, often the designation of a particular 
polymorphism is made by the name of a particular restric 
tion enZyme. This is not intended to imply that the only Way 
that the site can be identi?ed is by the use of that restriction 
enZyme. There are numerous databases and resources avail 
able to those of skill in the art to identify other restriction 
enZymes Which can be used to identify a particular poly 
morphism, for example http://World Wide Web at darWin 
.bio.geneseso.edu Which can give restriction enZymes upon 
analysis of a sequence and the polymorphism to be identi 
?ed. In fact, as disclosed in the teachings herein, there are 
numerous Ways of identifying a particular polymorphism or 
allele With alternate methods Which may not even include a 
restriction enzyme, but Which assay for the same genetic or 
proteomic alternative form. 
As used herein, “polymorphism” refers to DNA sequence 
variation in the cellular genomes of plants or animals, 
preferably mammals. These sequence variations include 
mutations, single nucleotide changes and insertions and 
deletions. “Single nucleotide polymorphism” (SNP) refers 
to those differences among samples of DNA in Which a 
single nucleotide base pair has been substituted by another. 
As used herein, “phenotype” refers to any observable or 
otherWise measurable physiological, morphological, bio 
logical, biochemical or clinical characteristic of an organ 
ism. 
As used herein, “genotype” refers to the genetic consti 
tution of an organism. More speci?cally, “genotyping” as 
used herein refers to the analysis of DNA in a sample 
obtained from a subject to determine the DNA sequence in 
a speci?c region of the genomeieg. at a gene that in?u 
ences a trait. The term “genotyping” may refer to the 
determination of DNA sequence at one or more polymorphic 
sites. 
As used herein, “haplotype” refers to the partial or com 
plete sequence of a segment of DNA from a single chro 
mosome. The DNA segment may include part of a gene, an 
entire gene, several genes, or a region devoid of genes (but 
Which perhaps contains a DNA sequence that regulates the 
function of nearby genes). The haplotype preserves infor 
mation about the phase of the polymorphic nucleotidesi 
that is, Which set of variances Were inherited from one parent 
(and are therefore on one chromosome), and Which from the 
other. Haplotypes are generally inherited as units, except in 
the event of a recombination during meiosis that occurs 
Within the DNA segment spanned by the haplotypeia rare 
occurrence for any given sequence in each generation. 
The term “associated Wit ” in connection With the rela 
tionship betWeen a genetic characteristic, e. g., a gene, allele, 
haplotype, or polymorphism, and a trait means that there is 
a statistically signi?cant level of relatedness betWeen them 
based on any generally accepted statistical measure of 
relatedness. Those skilled in the art are familiar With select 
ing an appropriate statistical measure for a particular experi 
mental situation or data set. 
The accompanying ?gures, Which are incorporated herein 
and Which constitute a part of this speci?cation, illustrate 
one embodiment of the invention and, together With the 
description, serve to explain the principles of the invention. 
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BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 shows a sequence comparison of the ghrelin 
protein (SEQ ID NOs: 1410). *The porcupine ghrelin 
sequence contains amino acid changes, Which are indicated 
With bold. 
FIGS. 2A4H are the results of the PCR-RFLP test dem 
onstrating the ability to detect the alleles. 
FIG. 3 shoWs the consensus sequence of the porcupine 
ghrelin fragment spanning exon 1 and 2 (447 bp) (SEQ ID 
NO: 11). The blocked regions indicate the coding region. 
The polymorphic site is underlined. N is not determined. 
FIG. 4 is a continuation of the consensus sequence of the 
porcupine ghrelin fragment spanning exon 3 and 4 (1.1 kb) 
(SEQ ID NO: 12). The blocked regions indicate the coding 
region. The polymorphic site is underlined. N is not deter 
mined. 
FIG. 5 shoWs the QTL analyses of the ghrelin in the 
Berkshire and Yorkshire crossed population for fatness traits 
on the pig chromosome 13. 
FIG. 6 shoWs the QTL analyses of the ghrelin in the 
Berkshire and Yorkshire crossed population for carcass traits 
on the pig chromosome 13. 
FIG. 7 shoWs the QTL analyses of the ghrelin in the 
Berkshire and Yorkshire crossed population for pork quality 
traits on the pig chromosome 13. 
DETAILED DESCRIPTION OF THE 
INVENTION 
Reference Will noW be made in detail to the presently 
referred embodiments of the invention, Which together With 
the folloWing examples, serve to explain the principles of the 
invention. 
Ghrelin has been identi?ed as an endogenous ligand to the 
groWth hormone (GH) secretagogue receptor, Which stimu 
lates GH release and food intake. 
According to the invention, applicants have identi?ed 
several single nucleotide polymorphisms (SNPs) in the pig 
ghrelin gene and these SNPs Were used for linkage mapping 
and association betWeen ghrelin polymorphisms and GH 
expression and plasma levels. Applicants have found that the 
ghrelin gene is linked With several markers on pig chromo 
some 13 of the PiGMaP, and the ISU Berkshire and York 
shire crossed reference families and is located under QTL 
for fatness and meat quality traits. In the PiGMap reference 
family, the Ghrelin gene maps close to S0223 and S0281. 
This gene is therefore linked to fat and groWth markers. 
Although GH mRNA concentration Was not associated With 
ghrelin polymorphisms, one of the polymorphisms, Type I 
of the BsrI polymorphism, Was signi?cantly associated With 
plasma GH concentration (p<0.03). This suggests that the 
ghrelin gene is a good candidate for the groWth and fatness 
Quantitative trait locus (QTL) reported on pig chromosome 
13 (FIGS. 547). 
Therefore, the invention relates to genetic markers for 
economically valuable traits in animals. The markers rep 
resent alleles that are associated signi?cantly With a groWth, 
appetite and fatness trait and thus provides a method of 
screening animals to determine those more likely to produce 
desired groWth, appetite and fatness (levels of one or all of 
these) When bred by identifying the presence or absence of 
a polymorphism in the Ghrelin gene that is so correlated. 
Thus, the invention relates to genetic markers and meth 
ods of identifying those markers in an animal of a particular 
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breed, strain, population, or group, Whereby the animal is 
more likely to yield meat of desired groWth, appetite and 
fatness. 
Any method of identifying the presence or absence of this 
marker may be used, including for example single-strand 
conformation polymorphism (SSCP) analysis, base excision 
sequence scanning (BESS), RFLP analysis, heteroduplex 
analysis, denaturing gradient gel electrophoresis, tempera 
ture gradient electrophoresis, allelic PCR, ligase chain reac 
tion direct sequencing, mini sequencing, nucleic acid 
hybridization, and micro-array-type detection of the Ghrelin 
gene, or other linked sequences of the Ghrelin gene. Also 
Within the scope of the invention includes assaying for 
protein conformational or sequences changes Which occur in 
the presence of this polymorphism. The polymorphism may 
or may not be the causative mutation but Will be indicative 
of the presence of this change and one may assay for the 
genetic or protein bases for the phenotypic difference. 
The folloWing is a general overvieW of techniques Which 
can be used to assay for the polymorphisms of the invention. 
In the present invention, a sample of genetic material is 
obtained from an animal. Samples can be obtained from 
blood, tissue, semen, etc. Generally, peripheral blood cells 
are used as the source, and the genetic material is DNA. A 
su?icient amount of cells are obtained to provide a su?icient 
amount of DNA for analysis. This amount Will be knoWn or 
readily determinable by those skilled in the art. The DNA is 
isolated from the blood cells by techniques knoWn to those 
skilled in the art. 
Isolation and Ampli?cation of Nucleic Acid 
Samples of genomic DNA are isolated from any conve 
nient source including saliva, buccal cells, hair roots, blood, 
cord blood, amniotic ?uid, interstitial ?uid, peritoneal ?uid, 
chorionic villus, and any other suitable cell or tissue sample 
With intact interphase nuclei or metaphase cells. The cells 
can be obtained from solid tissue as from a fresh or pre 
served organ or from a tissue sample or biopsy. The sample 
can contain compounds Which are not naturally intermixed 
With the biological material such as preservatives, antico 
agulants, buffers, ?xatives, nutrients, antibiotics, or the like. 
Methods for isolation of genomic DNA from these vari 
ous sources are described in, for example, Kirby, DNA 
Fingerprinting, An Introduction, W.H. Freeman & Co. NeW 
York (1992). Genomic DNA can also be isolated from 
cultured primary or secondary cell cultures or from trans 
formed cell lines derived from any of the aforementioned 
tissue samples. 
Samples of animal RNA can also be used. RNA can be 
isolated from tissues expressing the Ghrelin gene as 
described in Sambrook et al., supra. RNA can be total 
cellular RNA, mRNA, poly A+RNA, or any combination 
thereof. For best results, the RNA is puri?ed, but can also be 
unpuri?ed cytoplasmic RNA. RNA can be reverse tran 
scribed to form DNA Which is then used as the ampli?cation 
template, such that the PCR indirectly ampli?es a speci?c 
population of RNA transcripts. See, e.g., Sambrook, supra, 
Kawasaki et al., Chapter 8 in PCR Technology, (1992) supra, 
and Berg et al., Hum. Genet. 8516554658 (1990). 
PCR Ampli?cation 
The most common means for ampli?cation is polymerase 
chain reaction (PCR), as described in US. Pat. Nos. 4,683, 
195, 4,683,202, 4,965,188 each of Which is hereby incor 
porated by reference. If PCR is used to amplify the target 
regions in blood cells, hepariniZed Whole blood should be 
draWn in a sealed vacuum tube kept separated from other 
samples and handled With clean gloves. For best results, 
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blood should be processed immediately after collection; if 
this is impossible, it should be kept in a sealed container at 
4° C. until use. Cells in other physiological ?uids may also 
be assayed. When using any of these ?uids, the cells in the 
?uid should be separated from the ?uid component by 
centrifugation. 
Tissues should be roughly minced using a sterile, dispos 
able scalpel and a sterile needle (or tWo scalpels) in a 5 mm 
Petri dish. Procedures for removing para?in from tissue 
sections are described in a variety of specialiZed handbooks 
Well knoWn to those skilled in the art. 
To amplify a target nucleic acid sequence in a sample by 
PCR, the sequence must be accessible to the components of 
the ampli?cation system. One method of isolating target 
DNA is crude extraction Which is useful for relatively large 
samples. Brie?y, mononuclear cells from samples of blood, 
amniocytes from amniotic ?uid, cultured chorionic villus 
cells, or the like are isolated by layering on sterile Ficoll 
Hypaque gradient by standard procedures. Interphase cells 
are collected and Washed three times in sterile phosphate 
buffered saline before DNA extraction. If testing DNA from 
peripheral blood lymphocytes, an osmotic shock (treatment 
of the pellet for 10 sec With distilled Water) is suggested, 
folloWed by tWo additional Washings if residual red blood 
cells are visible folloWing the initial Washes. This Will 
prevent the inhibitory effect of the heme group carried by 
hemoglobin on the PCR reaction. If PCR testing is not 
performed immediately after sample collection, aliquots of 
106 cells can be pelleted in sterile Eppendorf tubes and the 
dry pellet froZen at —20° C. until use. 
The cells are resuspended (106 nucleated cells per 100 pl) 
in a buffer of 50 mM Tris-HCl (pH 8.3), 50 mM KCl 1.5 mM 
MgCl2, 0.5% TWeen 20, 0.5% NP40 supplemented With 100 
pg/ml of proteinase K. After incubating at 56° C. for 2 hr. the 
cells are heated to 95° C. for 10 min to inactivate the 
proteinase K and immediately moved to Wet ice (snap-cool). 
If gross aggregates are present, another cycle of digestion in 
the same buffer should be undertaken. Ten pl of this extract 
is used for ampli?cation. 
When extracting DNA from tissues, e.g., chorionic villus 
cells or con?uent cultured cells, the amount of the above 
mentioned buffer with proteinase K may vary according to 
the siZe of the tissue sample. The extract is incubated for 
4410 hrs at 50°460° C. and then at 95° C. for 10 minutes to 
inactivate the proteinase. During longer incubations, fresh 
proteinase K should be added after about 4 hr at the original 
concentration. 
When the sample contains a small number of cells, 
extraction may be accomplished by methods as described in 
Higuchi, “Simple and Rapid Preparation of Samples for 
PCR”, in PCR Technology, Ehrlich, H. A. (ed.), Stockton 
Press, NeW York, Which is incorporated herein by reference. 
PCR can be employed to amplify target regions in very small 
numbers of cells (100045000) derived from individual colo 
nies from bone marroW and peripheral blood cultures. The 
cells in the sample are suspended in 20 pl of PCR lysis buffer 
(10 mM Tris-HCl (pH 8.3), 50 mM KCl, 2.5 mM MgCl2, 0.1 
mg/ml gelatin, 0.45% NP40, 0.45% TWeen 20) and froZen 
until use. When PCR is to be performed, 0.6 pl of proteinase 
K (2 mg/ml) is added to the cells in the PCR lysis buffer. The 
sample is then heated to about 60° C. and incubated for 1 hr. 
Digestion is stopped through inactivation of the proteinase K 
by heating the samples to 95° C. for 10 min and then cooling 
on ice. 
A relatively easy procedure for extracting DNA for PCR 
is a salting out procedure adapted from the method described 
by Miller et al., Nucleic Acids Res. 16:1215 (1988), Which 
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is incorporated herein by reference. Mononuclear cells are 
separated on a Ficoll-Hypaque gradient. The cells are resus 
pended in 3 ml of lysis buffer (10 mM Tris-HCl, 400 mM 
NaCl, 2 mM Na2 EDTA, pH 8.2). Fifty pl of a 20 mg/ml 
solution of proteinase K and 150 pl of a 20% SDS solution 
are added to the cells and then incubated at 37° C. overnight. 
Rocking the tubes during incubation Will improve the diges 
tion of the sample. If the proteinase K digestion is incom 
plete after overnight incubation (fragments are still visible), 
an additional 50 pl of the 20 mg/ml proteinase K solution is 
mixed in the solution and incubated for another night at 37° 
C. on a gently rocking or rotating platform. Following 
adequate digestion, one ml of a 6M NaCl solution is added 
to the sample and vigorously mixed. The resulting solution 
is centrifuged for 15 minutes at 3000 rpm. The pellet 
contains the precipitated cellular proteins, While the super 
natant contains the DNA. The supernatant is removed to a 15 
ml tube that contains 4 ml of isopropanol. The contents of 
the tube are mixed gently until the Water and the alcohol 
phases have mixed and a White DNA precipitate has formed. 
The DNA precipitate is removed and dipped in a solution of 
70% ethanol and gently mixed. The DNA precipitate is 
removed from the ethanol and air-dried. The precipitate is 
placed in distilled Water and dissolved. 
Kits for the extraction of high-molecular Weight DNA for 
PCR include a Genomic isolation Kit A.S.A.P. (Boehringer 
Mannheim, Indianapolis, Ind.), Genomic DNA Isolation 
System (GIBCO BRL, Gaithersburg, Md.), Elu-Quik DNA 
Puri?cation Kit (Schleicher & Schuell, Keene, N. H.), DNA 
Extraction Kit (Stratagene, LaJolla, Calif.), TurboGen Iso 
lation Kit (Invitrogen, San Diego, Calif.), and the like. Use 
of these kits according to the manufacturer’s instructions is 
generally acceptable for puri?cation of DNA prior to prac 
ticing the methods of the present invention. 
The concentration and purity of the extracted DNA can be 
determined by spectrophotometric analysis of the absor 
bance of a diluted aliquot at 260 nm and 280 nm. After 
extraction of the DNA, PCR ampli?cation may proceed. The 
?rst step of each cycle of the PCR involves the separation of 
the nucleic acid duplex formed by the primer extension. 
Once the strands are separated, the next step in PCR 
involves hybridizing the separated strands With primers that 
?ank the target sequence. The primers are then extended to 
form complementary copies of the target strands. For suc 
cessful PCR ampli?cation, the primers are designed so that 
the position at Which each primer hybridiZes along a duplex 
sequence is such that an extension product synthesiZed from 
one primer, When separated from the template (comple 
ment), serves as a template for the extension of the other 
primer. The cycle of denaturation, hybridization, and exten 
sion is repeated as many times as necessary to obtain the 
desired amount of ampli?ed nucleic acid. 
In a particularly useful embodiment of PCR ampli?cation, 
strand separation is achieved by heating the reaction to a 
su?iciently high temperature for a su?icient time to cause 
the denaturation of the duplex but not to cause an irrevers 
ible denaturation of the polymerase (see US. Pat. No. 
4,965,188, incorporated herein by reference). Typical heat 
denaturation involves temperatures ranging from about 80° 
C. to 105° C. for times ranging from seconds to minutes. 
Strand separation, hoWever, can be accomplished by any 
suitable denaturing method including physical, chemical, or 
enZymatic means. Strand separation may be induced by a 
helicase, for example, or an enZyme capable of exhibiting 
helicase activity. For example, the enZyme RecA has heli 
case activity in the presence of ATP. The reaction conditions 
suitable for strand separation by helicases are knoWn in the 
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art (see Kuhn Holfman-Berling, 1978, CSH-Quantitative 
Biology, 43:63467; and Radding, 1982, Ann. Rev. Genetics 
16:4054436, each of Which is incorporated herein by refer 
ence). 
Template-dependent extension of primers in PCR is cata 
lyZed by a polymerizing agent in the presence of adequate 
amounts of four deoxyribonucleotide triphosphates (typi 
cally dATP, dGTP, dCTP, and dTTP) in a reaction medium 
comprised of the appropriate salts, metal cations, and pH 
buffering systems. Suitable polymerizing agents are 
enZymes knoWn to catalyZe template-dependent DNA syn 
thesis. In some cases, the target regions may encode at least 
a portion of a protein expressed by the cell. In this instance, 
mRNA may be used for ampli?cation of the target region. 
Alternatively, PCR can be used to generate a cDNA library 
from RNA for further ampli?cation, the initial template for 
primer extension is RNA. PolymeriZing agents suitable for 
synthesiZing a complementary, copy-DNA (cDNA) 
sequence from the RNA template are reverse transcriptase 
(RT), such as avian myeloblastosis virus RT, Moloney 
murine leukemia virus RT, or T hermus Zhermophilus (Tth) 
DNA polymerase, a thermostable DNA polymerase With 
reverse transcriptase activity marketed by Perkin Elmer 
Cetus, Inc. Typically, the RNA template is heat degraded 
during the ?rst denaturation step after the initial reverse 
transcription step leaving only DNA template. Suitable 
polymerases for use With a DNA template include, for 
example, E. coli DNA polymerase I or its KlenoW fragment, 
T4 DNA polymerase, Tth polymerase, and Taq polymerase, 
a heat-stable DNA polymerase isolated from T hermus 
aqualicus and commercially available from Perkin Elmer 
Cetus, Inc. The latter enZyme is Widely used in the ampli 
?cation and sequencing of nucleic acids. The reaction con 
ditions for using Taq polymerase are knoWn in the art and are 
described in Gelfand, 1989, PCR Technology, supra. 
Allele Speci?c PCR 
Allele-speci?c PCR differentiates betWeen target regions 
differing in the presence of absence of a variation or poly 
morphism. PCR ampli?cation primers are chosen Which 
bind only to certain alleles of the target sequence. This 
method is described by Gibbs, Nucleic Acid Res. 
1711242742448 (1989). 
Allele Speci?c Oligonucleotide Screening Methods 
Further diagnostic screening methods employ the allele 
speci?c oligonucleotide (ASO) screening methods, as 
described by Saiki et al., Nature 3241634166 (1986). Oli 
gonucleotides With one or more base pair mismatches are 
generated for any particular allele. ASO screening methods 
detect mismatches betWeen variant target genomic or PCR 
ampli?ed DNA and non-mutant oligonucleotides, shoWing 
decreased binding of the oligonucleotide relative to a mutant 
oligonucleotide. Oligonucleotide probes can be designed 
that under loW stringency Will bind to both polymorphic 
forms of the allele, but Which at high stringency, bind to the 
allele to Which they correspond. Alternatively, stringency 
conditions can be devised in Which an essentially binary 
response is obtained, i.e., anASO corresponding to a variant 
form of the target gene Will hybridiZe to that allele, and not 
to the Wildtype allele. 
Ligase Mediated Allele Detection Method 
Target regions of a test subject’s DNA can be compared 
With target regions in unaffected and affected family mem 
bers by ligase-mediated allele detection. See Landegren et 
al., Science 241:10741080 (1988). Ligase may also be used 
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to detect point mutations in the ligation ampli?cation reac 
tion described in Wu et al., Genomics 415604569 (1989). 
The ligation ampli?cation reaction (LAR) utiliZes ampli? 
cation of speci?c DNA sequence using sequential rounds of 
template dependent ligation as described in Wu, supra, and 
Barany, Proc. Nat. Acad. Sci. 8811894193 (1990). 
Denaturing Gradient Gel Electrophoresis 
Ampli?cation products generated using the polymerase 
chain reaction can be analyZed by the use of denaturing 
gradient gel electrophoresis. Different alleles can be identi 
?ed based on the different sequence-dependent melting 
properties and electrophoretic migration of DNA in solution. 
DNA molecules melt in segments, termed melting domains, 
under conditions of increased temperature or denaturation. 
Each melting domain melts cooperatively at a distinct, 
base-speci?c melting temperature (TM). Melting domains 
are at least 20 base pairs in length, and may be up to several 
hundred base pairs in length. 
Differentiation betWeen alleles based on sequence speci?c 
melting domain differences can be assessed using polyacry 
lamide gel electrophoresis, as described in Chapter 7 of 
Erlich, ed., PCR Technology, Principles and Applications 
for DNA Ampli?cation, W. H. Freeman and Co., NeW York 
(1992), the contents of Which are hereby incorporated by 
reference. 
Generally, a target region to be analyZed by denaturing 
gradient gel electrophoresis is ampli?ed using PCR primers 
?anking the target region. The ampli?ed PCR product is 
applied to a polyacrylamide gel With a linear denaturing 
gradient as described in Myers et al., Melh. Enzymol. 
1551501527 (1986), and Myers et al., in Genomic Analysis, 
A Practical Approach, K. Davies Ed. IRL Press Limited, 
Oxford, pp. 954139 (1988), the contents of Which are hereby 
incorporated by reference. The electrophoresis system is 
maintained at a temperature slightly beloW the Tm of the 
melting domains of the target sequences. 
In an alternative method of denaturing gradient gel elec 
trophoresis, the target sequences may be initially attached to 
a stretch of GC nucleotides, termed a GC clamp, as 
described in Chapter 7 of Erlich, supra. Preferably, at least 
80% of the nucleotides in the GC clamp are either guanine 
or cytosine. Preferably, the GC clamp is at least 30 bases 
long. This method is particularly suited to target sequences 
With high Tm’s. 
Generally, the target region is ampli?ed by the poly 
merase chain reaction as described above. One of the 
oligonucleotide PCR primers carries at its 5' end, the GC 
clamp region, at least 30 bases of the GC rich sequence, 
Which is incorporated into the 5' end of the target region 
during ampli?cation. The resulting ampli?ed target region is 
run on an electrophoresis gel under denaturing gradient 
conditions as described above. DNA fragments differing by 
a single base change Will migrate through the gel to different 
positions, Which may be visualiZed by ethidium bromide 
staining. 
Temperature Gradient Gel Electrophoresis 
Temperature gradient gel electrophoresis (TGGE) is 
based on the same underlying principles as denaturing 
gradient gel electrophoresis, except the denaturing gradient 
is produced by differences in temperature instead of differ 
ences in the concentration of a chemical denaturant. Stan 
dard TGGE utiliZes an electrophoresis apparatus With a 
temperature gradient running along the electrophoresis path. 
As samples migrate through a gel With a uniform concen 
tration of a chemical denaturant, they encounter increasing 
temperatures. An alternative method of TGGE, temporal 
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temperature gradient gel electrophoresis (TTGE or tTGGE) 
uses a steadily increasing temperature of the entire electro 
phoresis gel to achieve the same result. As the samples 
migrate through the gel the temperature of the entire gel 
increases, leading the samples to encounter increasing tem 
perature as they migrate through the gel. Preparation of 
samples, including PCR ampli?cation With incorporation of 
a GC clamp, and visualization of products are the same as 
for denaturing gradient gel electrophoresis. 
Single-Strand Conformation Polymorphism Analysis 
Target sequences or alleles at the Ghrelin locus can be 
differentiated using single-strand conformation polymor 
phism analysis, Which identi?es base differences by alter 
ation in electrophoretic migration of single stranded PCR 
products, as described in Orita et al., Proc. Nat. Acad. Sci. 
85:2766*2770 (1989). Ampli?ed PCR products can be gen 
erated as described above, and heated or otherWise dena 
tured, to form single stranded ampli?cation products. 
Single-stranded nucleic acids may refold or form secondary 
structures Which are partially dependent on the base 
sequence. Thus, electrophoretic mobility of single-stranded 
ampli?cation products can detect base-sequence difference 
between alleles or target sequences. 
Chemical or Enzymatic Cleavage of Mismatches 
Differences between target sequences can also be detected 
by differential chemical cleavage of mismatched base pairs, 
as described in Grompe et al., Am. J. Hum. Genet. 
48z2l2i222 (1991). In another method, differences betWeen 
target sequences can be detected by enzymatic cleavage of 
mismatched base pairs, as described in Nelson et al., Nature 
Genetics 4:11*18 (1993). Brie?y, genetic material from an 
animal and an affected family member may be used to 
generate mismatch free heterohybrid DNA duplexes. As 
used herein, “heterohybrid” means a DNA duplex strand 
comprising one strand of DNA from one animal, and a 
second DNA strand from another animal, usually an animal 
differing in the phenotype for the trait of interest. Positive 
selection for heterohybrids free of mismatches alloWs deter 
mination of small insertions, deletions or other polymor 
phisms that may be associated With Ghrelin polymorphisms. 
Non-gel Systems 
Other possible techniques include non-gel systems such 
as TAQMANTM (Perkin Elmer). In this system oligonucle 
otide PCR primers are designed that ?ank the mutation in 
question and alloW PCR ampli?cation of the region. A third 
oligonucleotide probe is then designed to hybridize to the 
region containing the base subject to change betWeen dif 
ferent alleles of the gene. This probe is labeled With ?uo 
rescent dyes at both the 5' and 3' ends. These dyes are chosen 
such that While in this proximity to each other the ?uores 
cence of one of them is quenched by the other and cannot be 
detected. Extension by Taq DNA polymerase from the PCR 
primer positioned 5' on the template relative to the probe 
leads to the cleavage of the dye attached to the 5' end of the 
annealed probe through the 5' nuclease activity of the Taq 
DNA polymerase. This removes the quenching e?fect alloW 
ing detection of the ?uorescence from the dye at the 3' end 
of the probe. The discrimination betWeen different DNA 
sequences arises through the fact that if the hybridization of 
the probe to the template molecule is not complete, i.e., there 
is a mismatch of some form, the cleavage of the dye does not 
take place. Thus only if the nucleotide sequence of the 
oligonucleotide probe is completely complimentary to the 
template molecule to Which it is bound Will quenching be 
removed. A reaction mix can contain two different probe 
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sequences each designed against different alleles that might 
be present thus alloWing the detection of both alleles in one 
reaction. 
Yet another technique includes an Invader Assay Which 
includes isothermic ampli?cation that relies on a catalytic 
release of ?uorescence. See Third Wave Technology at 
http://WorldWide Web at tWt.com. 
Non-PCR Based DNA Diagnostics 
The identi?cation of a DNA sequence linked to Ghrelin 
can be made Without an ampli?cation step, based on poly 
morphisms including restriction fragment length polymor 
phisms in an animal and a family member. Hybridization 
probes are generally oligonucleotides Which bind through 
complementary base pairing to all or part of a target nucleic 
acid. Probes typically bind target sequences lacking com 
plete complementarity With the probe sequence depending 
on the stringency of the hybridization conditions. The probes 
are preferably labeled directly or indirectly, such that by 
assaying for the presence or absence of the probe, one can 
detect the presence or absence of the target sequence. Direct 
labeling methods include radioisotope labeling, such as With 
32P or 358. Indirect labeling methods include ?uorescent 
tags, biotin complexes Which may be bound to avidin or 
streptavidin, or peptide or protein tags. Visual detection 
methods include photoluminescents, Texas red, rhodamine 
and its derivatives, red leuco dye and 3,3',5,5'-tetramethyl 
benzidine (TMB), ?uorescein, and its derivatives, dansyl, 
umbelliferone and the like or With horse radish peroxidase, 
alkaline phosphatase and the like. 
Hybridization probes include any nucleotide sequence 
capable of hybridizing to the porcine chromosome Where 
Ghrelin resides, and thus de?ning a genetic marker linked to 
Ghrelin, including a restriction fragment length polymor 
phism, a hypervariable region, repetitive element, or a 
variable number tandem repeat. Hybridization probes can be 
any gene or a suitable analog. Further suitable hybridization 
probes include exon fragments or portions of cDNAs or 
genes knoWn to map to the relevant region of the chromo 
some. 
Preferred tandem repeat hybridization probes for use 
according to the present invention are those that recognize a 
small number of fragments at a speci?c locus at high 
stringency hybridization conditions, or that recognize a 
larger number of fragments at that locus When the stringency 
conditions are loWered. 
One or more additional restriction enzymes and/or probes 
and/or primers can be used. Additional enzymes, constructed 
probes, and primers can be determined by routine experi 
mentation by those of ordinary skill in the art and are 
intended to be Within the scope of the invention. 
Although the methods described herein may be in terms 
of the use of a single restriction enzyme and a single set of 
primers, the methods are not so limited. One or more 
additional restriction enzymes and/or probes and/ or primers 
can be used, if desired. Indeed in some situations it may be 
preferable to use combinations of markers giving speci?c 
haplotypes. Additional enzymes, constructed probes and 
primers can be determined through routine experimentation, 
combined With the teachings provided and incorporated 
herein. 
According to the invention, polymorphisms in the Ghrelin 
gene have been identi?ed Which have an association With 
groWth, appetite and fatness. The presence or absence of the 
markers, in one embodiment may be assayed by PCR RFLP 
analysis using the restriction endonucleases and ampli?ca 
tion primers may be designed using analogous human, pig or 
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other Ghrelin sequences due to the high homology in the 
region surrounding the polymorphisms, or may be designed 
using knoWn Ghrelin gene sequence data as exempli?ed in 
GenBank or even designed from sequences obtained from 
linkage data from closely surrounding genes based upon the 
teachings and references herein. The sequences surrounding 
the polymorphism Will facilitate the development of alter 
nate PCR tests in Which a primer of about 4*30 contiguous 
bases taken from the sequence immediately adjacent to the 
polymorphism is used in connection With a polymerase 
chain reaction to greatly amplify the region before treatment 
With the desired restriction enzyme. The primers need not be 
the exact complement; substantially equivalent sequences 
are acceptable. The design of primers for ampli?cation by 
PCR is knoWn to those of skill in the art and is discussed in 
detail in Short Protocols in Molecular Biology, 4”’ ed., 
Ausubel Ed., John Wiley and Sons (1999). The folloWing is 
a brief description of primer design. 
Primer Design Strategy 
Increased use of polymerase chain reaction (PCR) meth 
ods has stimulated the development of many programs to aid 
in the design or selection of oligonucleotides used as primers 
for PCR. Four examples of such programs that are freely 
available via the Internet are: PRIMER by Mark Daly and 
Steve Lincoln of the Whitehead Institute (UNIX, VMS, 
DOS, and Macintosh), Oligonucleotide Selection Program 
(OSP) by Phil Green and LaDeana Hiller of Washington 
University in St. Louis (UNIX, VMS, DOS, and Macintosh), 
PGEN by Yoshi (DOS only), and Amplify by Bill Engels of 
the University of Wisconsin (Macintosh only). Generally 
these programs help in the design of PCR primers by 
searching for bits of knoWn repeated-sequence elements and 
then optimizing the Tm by analyzing the length and GC 
content of a putative primer. Commercial softWare is also 
available and primer selection procedures are rapidly being 
included in most general sequence analysis packages. 
Sequencing and PCR Primers 
Designing oligonucleotides for use as either sequencing 
or PCR primers requires selection of an appropriate 
sequence that speci?cally recognizes the target, and then 
testing the sequence to eliminate the possibility that the 
oligonucleotide Will have a stable secondary structure. 
Inverted repeats in the sequence can be identi?ed using a 
repeat-identi?cation or RNA-folding program such as those 
described above (see prediction of Nucleic Acid Structure). 
If a possible stem structure is observed, the sequence of the 
primer can be shifted a feW nucleotides in either direction to 
minimize the predicted secondary structure. The sequence of 
the oligonucleotide should also be compared With the 
sequences of both strands of the appropriate vector and 
insert DNA. Obviously, a sequencing primer should only 
have a single match to the target DNA. It is also advisable 
to exclude primers that have only a single mismatch With an 
undesired target DNA sequence. For PCR primers used to 
amplify genomic DNA, the primer sequence should be 
compared to the sequences in the GenBank database to 
determine if any signi?cant matches occur. If the oligonucle 
otide sequence is present in any knoWn DNA sequence or, 
more importantly, in any knoWn repetitive elements, the 
primer sequence should be changed. 
The methods and materials of the invention may also be 
used more generally to evaluate pig DNA, genetically type 
individual pigs, and detect genetic differences in pigs. In 
particular, a sample of pig genomic DNA may be evaluated 
by reference to one or more controls to determine if a 
polymorphism in the Ghrelin gene is present. Preferably, 
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RFLP analysis is performed With respect to the pig Ghrelin 
gene, and the results are compared With a control. The 
control is the result of a RFLP analysis of the pig Ghrelin 
gene of a different pig Where the polymorphism of the pig 
Ghrelin gene is knoWn. Similarly, the Ghrelin genotype of a 
pig may be determined by obtaining a sample of its genomic 
DNA, conducting RFLP analysis of the Ghrelin gene in the 
DNA, and comparing the results With a control. Again, the 
control is the result of RFLP analysis of the Ghrelin gene of 
a different pig. The results genetically type the pig by 
specifying the polymorphism(s) in its Ghrelin gene. Finally, 
genetic differences among pigs can be detected by obtaining 
samples of the genomic DNA from at least tWo pigs, 
identifying the presence or absence of a polymorphism in 
the Ghrelin gene, and comparing the results. 
These assays are useful for identifying the genetic mark 
ers relating to groWth, appetite and fatness, as discussed 
above, for identifying other polymorphisms in the Ghrelin 
gene that may be correlated With other characteristics, such 
as litter size and for the general scienti?c analysis of pig 
genotypes and phenotypes. 
The examples and methods herein disclose certain genes 
Which have been identi?ed to have a polymorphism Which 
is associated either positively or negatively With a bene?cial 
trait that Will have an effect on groWth, appetite and fatness 
for animals carrying this polymorphism. The identi?cation 
of the existence of a polymorphism Within a gene is often 
made by a single base alternative that results in a restriction 
site in certain allelic forms. A certain allele, hoWever, as 
demonstrated and discussed herein, may have a number of 
base changes associated With it that could be assayed for 
Which are indicative of the same polymorphism (allele). 
Further, other genetic markers or genes may be linked to the 
polymorphisms disclosed herein so that assays may involve 
identi?cation of other genes or gene fragments, but Which 
ultimately rely upon genetic characterization of animals for 
the same polymorphism. Any assay Which sorts and identi 
?es animals based upon the allelic dilferences disclosed 
herein are intended to be included Within the scope of this 
invention. 
Linkage Analysis 
Linkage analysis may be performed alone, or in combi 
nation With direct detection of phenotypically evident poly 
morphisms. The use of microsatellite markers for genotyp 
ing is Well documented. For examples, see Mans?eld et al. 
(1994) Genomics 24z225i233; and Ziegle et al. (1992) 
Genomics l4:l026*l 031. The use of SNPs for genotyping 
is illustrated in Underhill et al. (1996) Proc. Natl. Acad. Sci. 
USA 93zl96i200. 
Genetic linkage maps shoW the relative locations of 
speci?c DNA markers along a chromosome. Any inherited 
physical or molecular characteristic that differs among indi 
viduals and is easily detectable in the laboratory is a poten 
tial genetic marker. DNA sequence polymorphisms are use 
ful markers because they are plentiful and easy to 
characterize precisely. Many such polymorphisms are 
located in non-coding regions and do not affect the pheno 
type of the organism, yet they are detectable at the DNA 
level and can be used as markers. Examples include restric 
tion fragment length polymorphisms (RFLPs), Which re?ect 
sequence variations in DNA sites or differences in the length 
of the product, Which can be cleaved by DNA restriction 
enzymes, microsatellite markers, Which are short repeated 
sequences that vary in the number of repeated units, single 
nucleotide polymorphisms (SNPs), and the like. 
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The “linkage” aspect of the map is a measure of hoW 
frequently tWo markers are inherited together. The closer the 
markers are to each other physically, the less likely a 
recombination event Will fall betWeen and separate them. 
Recombination frequency thus provides an estimate of the 
distance betWeen tWo markers. The value of the genetic map 
is that an inherited trait can be located on the map by 
folloWing the inheritance of a DNA marker present in 
affected animals, but absent in una?fected animals, even 
though the molecular basis for the trait may not yet be 
understood. 
An emerging class of marker for genetic analysis of the 
single nucleotide polymorphism, and other simple polymor 
phisms, e.g. deletions, double nucleotide polymorphisms. 
SNPs are generally biallelic systems, that is, there are tWo 
alleles that a population may have for any particular marker. 
This means that the information content per SNP marker is 
relatively loW When compared to microsatellite markers, 
Which may have upWards of 10 alleles. SNPs also tend to be 
very population-speci?c; a marker that is polymorphic in 
one population may not be very polymorphic in another. 
SNP markers offer a number of bene?ts that Will make 
them an increasingly valuable tool. SNPs, found approxi 
mately every kilobase (see Wang et al. (1998) Science 
280: 107741082), offer the potential for generating very high 
density genetic maps, Which Will be extremely useful for 
developing haplotyping systems for genes or regions of 
interest, and because of the nature of SNPs, they may in fact 
be the polymorphisms associated With the traits under study. 
The loW mutation rate of SNPs also makes them excellent 
markers for studying complex genetic traits. 
One of skill in the art, once a polymorphism has been 
identi?ed and a correlation to a particular trait established, 
Will understand that there are many Ways to genotype 
animals for this polymorphism. The design of such alterna 
tive tests merely represent optimization of parameters 
knoWn to those of skill in the art and are intended to be 
Within the scope of this invention as fully described herein. 
The folloWing examples serve to better illustrate the 
invention described herein and are not intended to limit the 
invention in any Way. Those skilled in the art Will recognize 
that there are several different parameters Which may be 
altered using routine experimentation and are intended to be 
Within the scope of this invention. 
EXAMPLE 1 
Ghrelin: PCR-RFLP Tests 
Primers for Mix 1: 450 bp 
(SEQ ID NO:l3) 
GHR-lF: 5' CAG GAA GAC CAG CTG AGG c 3' 
(SEQ ID NO:14) 
GHR-2R: 5' GAA CCG GAT TTC CAG CTT GT 3' 
Primers for Mix 2: 1100 bp 
(SEQ ID NO:15) 
GHR-3F: GTT GGG ATC AAG TTG TCA GG 3' 
(SEQ ID NO:16) 
GHR-4R: CCT CAG AGC TGG GTG TGA TA 3' 
20 
25 
30 
35 
40 
45 
50 
55 
60 
65 
20 
PCR conditions: 
Mix 1: Mix 2: 
10X Promega Buffer 1 0 }1L 10X Promega Buffer 1.0 11L 
25 mM MgCl2 0 6 11L 25 mM MgCl2 0.5 11L 
dNTPs mix (2.5 mM 0 5 }1L dNTPs mix (2.5 mM 0.5 11L 
each) each) 
25 prnol/pL GHR-lF 0 1 11L 25 prnol/pL GHR-3F 0.1 11L 
25 prnol/pL GHR-2R 0 1 11L 25 prnol/pL GHR-4R 0.1 11L 
dd sterile H2O 7.4 11L dd sterile H2O 7.5 11L 
Taq Polymerase (5 U/ 0.07 pL Taq Polymerase (5 U/pL) 0.07 }1L 
11L) Genomic DNA (12.5 119 1.0 11L 
Genomic DNA 1.0 }1L 11L) 
(12.5 nguL) 
1. Ran the folloWing program: 940 C. for 2 min; 35 cycles 
of 94° C. for 30 sec, 540 C. (Mix 1) and 58° C. (Mix 2) 
1 min, and 72° C. 1 min 30 sec; folloWed by a ?nal 
extension at 72° C. for 10 min. 
2. Checked 3 pL of the PCR reaction on a standard 1% 
agarose gel to con?rm ampli?cation success and clean 
negative control. 
Digestion Reactions: 
Added 5 uL to each reaction tube containing the DNA. 
lncubated at the recommended temperature from the manu 
facture for at least 4 hours to overnight. Mixed loading dyes 
With digestion reaction and loaded the total volume on a 3% 
agarose gel. 
1. Mspl Polymorphism of Mix 1 PCR Product 
PCR product 5.0 11L 
10X NE Buifer 2 1 0 }1L 
BSA (10 mg/ml) 0 3 }1L 
Mspl enzyme (20 U/uL) 0 3 }1L 
dd sterile H20 3 6 }1L 
Results from the Mspl digestion of Mix 1 are shoWn in FIG. 2A. 
2. Alul polymorphism of the Mix 1 PCR Product 
This test Was not able to determine betWeen 12 and 22 
genotypes because the binding site of the GHR-2R primer 
contains the polymorphism. 
PCR product 5.0 11L 
10X NE Buifer 2 1.0 11L 
BSA (10 mg/ml) 0.3 11L 
Alul enzyme (10 U/uL) 0.5 11L 
dd sterile H2O 3.5 11L 
Results from the Alul digestion of Mix 1 are shoWn in FIG. 2B. 
3. Rsal Polymorphism of the Mix 2 PCR Product 
PCR product 5.0 11L 
10X NE Buifer 1 1.0 11L 
BSA (10 mg/ml) 0.3 11L 
Rsal enzyme (10 U/uL) 0.5 11L 
dd sterile H2O 3.5 11L 
Results from the Rsal digestion of the Mix 2 are shoWn in FIG. 2C. 








